People channel feed

Alk­er­mes' head of ear­ly R&D jumps ship to new­ly cre­at­ed Har­vard role

6 years ago

HH­MI dis­crim­i­nat­ed against two Asian Amer­i­can women in­ves­ti­ga­tors, law­suits al­lege

6 years ago
Discovery

David Meek hands in his CEO ti­tle at Ipsen, leap­ing across the At­lantic to run a start­up prep­ping its first US drug launch

6 years ago

Bris­tol-My­er­s' strat­e­gy, BD chief Paul Bion­di ex­it­ed the com­pa­ny — just ahead of the $74B Cel­gene deal close

6 years ago

South Ko­rea jails 3 Sam­sung ex­ecs for de­stroy­ing ev­i­dence in Bi­o­Log­ics probe

6 years ago
FDA+

One of Wall Street’s most high-pro­file hedge funds push­es Alex­ion's CEO to the auc­tion block — and he's not budg­ing

6 years ago

Sue Desmond-Hell­mann says it's time for her to leave the Gates Foun­da­tion. Strat­e­gy chief Mark Suz­man will now take the helm

6 years ago

As it shops for new deals, Akcea hires for­mer GSK ex­ec as COO

6 years ago
R&D

Bio­gen comes un­der re­newed fire as a lead­ing Alzheimer's ex­pert rais­es se­ri­ous ques­tions about the ad­u­canum­ab da­ta

6 years ago
R&D

Sen­ate com­mit­tee backs Stephen Hahn as the next FDA com­mis­sion­er

6 years ago
FDA+

Agios taps Bris­tol-My­ers vet Bruce Car to re­place re­tir­ing CSO

6 years ago

Ex-Pur­due CEO stands to earn a huge wind­fall in No­var­tis' buy­out of the Med­i­cines Co

6 years ago
Deals
R&D

Sanofi's strat­e­gy head to re­tire by month end, as com­pa­ny gears up for De­cem­ber strate­gic up­date

6 years ago
Pharma

Mor­phoSys’ chief sci­en­tist hits the ex­it, trig­ger­ing R&D re­or­ga­ni­za­tion as they shift fo­cus to US in an­tic­i­pa­tion of loom­ing FDA ap­proval

6 years ago
R&D

Am­gen chops 172 more staffers in R&D, op­er­a­tions and sales amid neu­ro­science ex­it, rev­enue down­turn

6 years ago

As­traZeneca los­es an­oth­er ex­ec­u­tive to biotech, as Badrul Chowd­hury moves to Savara

6 years ago
Pharma

Supreme Court turns down Mar­tin Shkre­li's lat­est ap­peal, leav­ing 'phar­ma bro' to 7-year sen­tence

6 years ago

Flag­ship woos No­var­tis top deal­mak­er Prakash Ra­man in move to get the BD ball rolling ear­ly

6 years ago
Financing

Spe­cial re­port: Twen­ty ex­tra­or­di­nary women in bio­phar­ma R&D who worked their way to the top

6 years ago
Special

An­oth­er ex-Shire re­search ex­ec heads out, grab­bing top R&D job at deal-hun­gry Ipsen as post-buy­out ex­o­dus con­tin­ues

6 years ago
R&D

Right on dead­line, Trump taps Stephen Hahn as new FDA com­mish. Now what?

6 years ago
Pharma

UK's John­son, Cor­byn bick­er over US trade and Ver­tex deal

6 years ago
Pharma

Boston ju­ry finds biotech CEO guilty of fleec­ing in­vestors, ob­struc­tion of jus­tice

6 years ago

Google’s ven­ture arm re­cruits a Har­vard/Tesaro vet to help plant the seeds for a sec­ond on­col­o­gy R&D rev­o­lu­tion

6 years ago
Financing
First page Previous page 72737475767778 Next page Last page
A service from the Financial Times